Phase II Investigation of 99mTc-rBitistatin for Imaging Venous Thrombosis
Status:
Withdrawn
Trial end date:
2017-03-01
Target enrollment:
Participant gender:
Summary
99mTc-rBitistatin is a radiolabeled polypeptide which is designed to stick to blood clots so
that the blood clots can be detected by imaging. The purpose of this trial is to evaluate in
patients the safety of 99mTc-rBitistatin and its ability to locate blood clots in the arms
and legs.